IEC Letter No. SSCASRH/IEC/003/21
CTRI Regd. No. CTRI/2021/08/036025
Aim of the Study
To find out the efficacy of NF2 and NF4 in the treatment of COVID19 Positive Patient
Objective of the Study
1) To evaluate the assessment of subjective and objective parameters of COVID19 positive patienton NF2 and NF4 blind medicinein the treatment procedure
2) To evaluate the efficacy of double blind medicines
3) To establish Ayurveda/Siddha medicine for the treatment of COVID19 positive patients
Research started: 10/09/2021
End of Research: 29/09/2021
Girish shah
What is blind medicine